from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0679c/-

LFCtreatmentdescriptionclass of inhibitor

-0.627

Amikacinug/mL Amikacintranslation

-0.629

Cap5-10ug/mL Capreomycintranslation

-0.091

Rox10-50 ug/mL Roxithromycintranslation

-0.496

SM2-5 ug/mL Streptomycintranslation

-1.064

Tet5-10 ug/mL Tetracyclinetranslation

-0.149

Rif0.2-5ug/mL Rifampicintranscription

0.152

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.486

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.440

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.741

CPZ10-50 ug/mL Chlorpromazinerespiration

1.473

Clofazimine10-13 ug/mL Clofaziminerespiration

0.612

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.621

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.004

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.706

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.247

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.389

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.662

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.371

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.448

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.419

KCN5-20 ug/mL Potassium cyaniderespiration

-0.175

NaN30.2-2 mM Sodium aziderespiration

0.770

Nigericin50 uM Nigericinrespiration

0.638

TRC10-150 ug/mL Triclosanrespiration

-0.702

TRZ10-25 ug/mL Thioridazinerespiration

-2.911

Valinomycin0.5-10 uM Valinomycinrespiration

1.361

ZnSO42 mM ZnSO4respiration

-0.051

menadione6-10 ug/mL Menadionerespiration

0.640

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.260

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.676

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.541

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.473

NRP_1Non-replicating persistence stage 1dosRassociated

0.098

Amp0.2mg/mL AmpicillincellWall

-0.480

Cephalexin20-100 ug/mL CephalexincellWall

-0.230

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.157

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.058

EMB10-20 ug/mL EthambutolcellWall

0.082

Eta12-40 ug/mL EthionamidecellWall

-0.221

INH0.2-0.4 ug/mL IsoniazidcellWall

0.041

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.597

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.038

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.274

BZA0.12 mg/mL BenzamidearomaticAmides

0.829

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.075

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.351

H2O24 mM hydrogen peroxideDNAdamaging

-0.492

Levo10 ug/mL LevofloxacinDNAdamaging

-0.074

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.493

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.192

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.575

UVUV-irradiationDNAdamaging

-0.512

ARP41-4 ug/mL Antitubercular compound ARP4?

0.266

Antimycin12.5-50 ug/mL Antimycin A?

0.154

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.309

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.467

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.101

PA8240.2-2 ug/mL PA-824?

-1.701

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.672

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.722

Verapamil50 uM Verapamil?

0.060

mercaptoethanol2 mM 2-Mercaptoethanol?

0.908

methoxatin10-20 ug/mL Methoxatin?